Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction V Melenovsky, SJ Hwang, MM Redfield, R Zakeri, G Lin, BA Borlaug Circulation: Heart Failure 8 (2), 295-303, 2015 | 480 | 2015 |
Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study R Zakeri, AM Chamberlain, VL Roger, MM Redfield Circulation 128 (10), 1085-1093, 2013 | 376 | 2013 |
Defining the relationship between COPD and CVD: what are the implications for clinical practice? AD Morgan, R Zakeri, JK Quint Therapeutic advances in respiratory disease 12, 1753465817750524, 2018 | 340 | 2018 |
Relation between mild renal dysfunction and outcomes after coronary artery bypass grafting R Zakeri, N Freemantle, V Barnett, GW Lipkin, RS Bonser, TR Graham, ... Circulation 112 (9_supplement), I-270-I-275, 2005 | 263 | 2005 |
Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study MJ Landray, JR Emberson, L Blackwell, T Dasgupta, R Zakeri, ... American Journal of Kidney Diseases 56 (6), 1082-1094, 2010 | 203 | 2010 |
Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study R Zakeri, BA Borlaug, SE McNulty, SF Mohammed, GD Lewis, ... Circulation: Heart Failure 7 (1), 123-130, 2014 | 194 | 2014 |
Evaluation and improvement of the National Early Warning Score (NEWS2) for COVID-19: a multi-hospital study E Carr, R Bendayan, D Bean, M Stammers, W Wang, H Zhang, T Searle, ... BMC medicine 19 (1), 1-16, 2021 | 151 | 2021 |
Treatment with ACE-inhibitors is associated with less severe disease with SARS-Covid-19 infection in a multi-site UK acute Hospital Trust DM Bean, Z Kraljevic, T Searle, R Bendayan, A Pickles, A Folarin, ... MedRxiv, 2020.04. 07.20056788, 2020 | 135* | 2020 |
Heart failure with preserved ejection fraction: controversies, challenges and future directions R Zakeri, MR Cowie Heart 104 (5), 377-384, 2018 | 125 | 2018 |
Angiotensin‐converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID‐19 infection in a multi‐site UK acute hospital trust DM Bean, Z Kraljevic, T Searle, R Bendayan, OG Kevin, A Pickles, ... European journal of heart failure 22 (6), 967-974, 2020 | 123 | 2020 |
Reporting of sex as a variable in cardiovascular studies using cultured cells KE Taylor, C Vallejo-Giraldo, NS Schaible, R Zakeri, VM Miller Biology of sex differences 2, 1-7, 2011 | 105 | 2011 |
Left atrial remodeling and atrioventricular coupling in a canine model of early heart failure with preserved ejection fraction R Zakeri, G Moulay, Q Chai, O Ogut, S Hussain, H Takahama, T Lu, ... Circulation: Heart Failure 9 (10), e003238, 2016 | 98 | 2016 |
A case-control and cohort study to determine the relationship between ethnic background and severe COVID-19 R Zakeri, R Bendayan, M Ashworth, DM Bean, H Dodhia, S Durbaba, ... EClinicalMedicine 28, 2020 | 65 | 2020 |
Accelerometer-measured daily activity in heart failure with preserved ejection fraction: clinical correlates and association with standard heart failure severity indices D Snipelisky, J Kelly, JA Levine, GA Koepp, KJ Anstrom, SE McNulty, ... Circulation: Heart Failure 10 (6), e003878, 2017 | 64 | 2017 |
Resting ventricular–vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX Trial Ancillary Study SF Mohammed, BA Borlaug, S McNulty, GD Lewis, G Lin, R Zakeri, ... Circulation: Heart Failure 7 (4), 580-589, 2014 | 57 | 2014 |
Urinary C-type natriuretic peptide: a new heart failure biomarker R Zakeri, SJ Sangaralingham, SM Sandberg, DM Heublein, CG Scott, ... JACC: Heart Failure 1 (2), 170-177, 2013 | 56 | 2013 |
Temporal trends in the incidence, treatment patterns, and outcomes of coronary artery disease and peripheral artery disease in the UK, 2006–2015 V Sundaram, C Bloom, R Zakeri, J Halcox, A Cohen, K Bowrin, JB Briere, ... European heart journal 41 (17), 1636-1649, 2020 | 49 | 2020 |
Beta-blocker therapy in patients with COPD: a systematic literature review and meta-analysis with multiple treatment comparison C Gulea, R Zakeri, V Alderman, A Morgan, J Ross, JK Quint Respiratory research 22, 1-14, 2021 | 48 | 2021 |
Epidemiology of right ventricular dysfunction in heart failure with preserved ejection fraction R Zakeri, SF Mohammed Current heart failure reports 12, 295-301, 2015 | 46 | 2015 |
The emperor's new clothes: PDE5 and the heart CV Degen, K Bishu, R Zakeri, O Ogut, MM Redfield, FV Brozovich PLoS One 10 (3), e0118664, 2015 | 45 | 2015 |